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Abstract
Endoscopic imaging is in part responsible for the recent drop in deaths from gastrointestinal cancers and
also for detecting pre-cancerous and non-cancerous conditions and allowing them to be treated
effectively, although techniques are far from perfect. Endoscopic imaging has evolved considerably from
fiberopticsystems50yearsagotohighresolutionandhighdefinitionsystemsusedatpresent.Moreover,
image enhancement using filters and processors has led to the technique of ‘electronic chromoendo-
scopy’tovisualizemucosalbloodvesselsandsurfacepitpatternsclearly.Magnificationbyopticalzoomor
confocal laser microscopy has enabled real time diagnosis and ‘virtual histology’. These techniques have
contributed to the earlydetection, assessment and treatmentofvarious gastrointestinalpathologies.The
focus of future research is directed towards molecular targeted imaging.
Introduction
Gastrointestinal cancers account for around 17% of
deaths from cancer, and will kill almost 280,000 people
in the US alone this year according to estimates from the
American Cancer Association. In most cases, these deaths
are entirely preventable if they are detected early enough
and, in recent years, early detection has improved and
death rates have dropped. Endoscopic imaging is in part
responsible for this drop and also for detecting pre-
cancerous and non-cancerous conditions and allowing
them to be treated effectively, although techniques are
far from perfect. Recent technological advances offer the
hope that early detection of these conditions can be
much improved.
The flexible endoscopy technique to visualize the gastro-
intestinal tract was revolutionized with the advent of
fiber optic endoscopes in 1957 by Basil Hirschowitz [1].
The fiber optic systems used multiple optic viewing
bundles transmitting light focused on to the face of each
fiber by repeated internal reflections. The resulting image
constructed at the top of the bundle was viewed by the
operator with a focusing lens. The main disadvantage
with this technique was the frequent rupture of bundles
with repeateduse, thus resulting in lossof clarity ofimages.
The introduction of video endoscopy was the next major
technological development, which enabled the operator to
view real time images on a monitor. This was possible by
the advent of charged coupled devices comprising an array
of several thousand individual photo cells known as
picture elements (pixels). They receive photons reflected
back from the mucosal surface and produce electrons in
proportion to the amount of light received. The variable
levels of charge are sent electronically to a video processor,
which transposes this analog information into digital data
that is processed to produce an image on a television
monitor. The last decade has seen major advancements in
the pixel densities of the charged coupled devices, and
definition of the monitor, thus enabling us to view the
mucosal surface in significantly more detail.
High resolution and magnification endoscopy
Early video endoscopes were equipped with charged
coupled devices of approximately 200,000 pixels with a
focal length of 1-2 cm from the mucosal surface. These
images allow the real time diagnosis of pathology such as
inflammation (colitis and gastritis) as well as established
cancer; however, it did not allow visualization of more
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and early mucosal neoplasia (dysplasia and intramucosal
cancer). Current endoscopes now contain digital chips of
up to 1.4 million pixels and the processed high quality
images are being displayed on high definition monitors.
Endoscopes equipped with a movable lens at the tip of the
scope can provide optical magnification up to 150 times,
which, in combination with the latest high resolution
charged coupled devices, allows greatly enhanced mucosal
detail. Pit patterns and vascular architecture can now be
appreciated in fine detail, whereby certain characteristics
are associated with specific pathology. Consequently, the
role of high resolution endoscopy and magnification
endoscopy in the diagnosis of epithelial pathology has
been investigated over the last few years.
Chromoendoscopy
Many studies have utilised dyes that enhance different
aspectsofthemucosalpattern.Indigocarmine,forexample,
concentrates within the grooves or cavities of the mucosa,
enhancingthesurfacearchitectureandhighlightingelevated
lesions. Lugol’s iodine on the other hand is not taken up by
areas of dysplasia within the esophagus. Studies in Barrett’s
esophagus using high resolution endoscopy, magnification
endoscopy and indigo carmine sprayed on the epithelial
surface have shown promise in imaging of intestinal
metaplasia and dysplasia and patterns in the mucosal
architecture correlating with pathology [2,3]. In contrast,
application of other agents to the epithelium, such as acetic
acid and methylene blue, along with magnification in the
diagnosis of dysplasia has shown varying results [4-6].
Promising results were shown using magnification endo-
scopytoidentifygastricatrophy,H.pylorigastritisandceliac
disease using magnification in uncontrolled studies [7-10],
but magnification endoscopy alone was found to have a
modest accuracy in differentiating colonic adenomatous
polyps from hyperplastic polyps. However, when magnifi-
cation endoscopy is combined with chromoscopy, the
diagnostic accuracy was significantly better at 90% [11,12].
Electronic chromoendoscopy
Electronic chromoendoscopy has the advantage of
avoiding cumbersome dye spray. Narrow band imaging
(Olympus Corporation) uses filter technology to
increase the proportion of blue light and narrows the
band widths of blue (390-445 nm) and green (530-
550 nm) light. The shorter wavelength blue light enhances
the mucosal vasculature patterns allowing identification of
subtle abnormalities such as enhanced and irregular
vasculature, often present in neoplasia and inflammation.
Flexible spectral imaging colour enhancement (FICE)
(Fujinon endoscopy) and I-Scan (Pentax Medical) are
based on a new computed spectral estimation technology
(see Figures 1 and 2). These techniques transform an
ordinary endoscopic image taken from the video processor
and arithmetically process the reflected photons to
reconstitute virtual images by increasing the relative
intensity of narrowed blue light to a maximum and by
decreasing narrowed red and green light to a minimum.
Detection of pathology
The studies ofnarrow bandimaging in detecting dysplasia
in Barrett’s esophagus have yielded conflicting results.
Figure 1. Barrett’s dysplasia with i-scan surface enhancement
The image is taken with a Pentax EG2990i gastroecope and an EPKi
processor with the addition of I-Scan surface enhancement and demon-
strates Barrett’s epithelium. There is a glandular and irregular mucosa with
coiled vessels and enhanced vasculature in keeping with high grade dysplasia.
Figure 2. Barrett’s dysplasia with I-Scan tone enhancement
Use of tone enhancement with I-Scan highlights the vasculature and
demonstrates an irregular glandular mucosal pattern with deep grooves and
prominent vessels suggestive of Barrett’s high grade dysplasia.
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detection of dysplasia in targeted biopsies than with high
resolutionendoscopy[13],othershavenot[14].However,
narrow band imaging appears to be most beneficial in
detecting pathology when used by less experienced
endoscopists. When applied by experts, the benefit of
narrow band imaging was less evident. FICE was found to
be comparable to acetic acid chromoscopy in detecting
Barrett’s dysplasiain arandomized trial[15].Randomized
trials using FICE in colonic adenoma detection failed to
show any additional advantage over high resolution
endoscopy or conventional chromoscopy [16,17]. How-
ever, FICE was noted to improve detection of small bowel
lesions compared with capsule endoscopy [18]. High
definition colonoscopy with I-Scan was found to be
superior to standard video endoscopy in detecting colonic
neoplasia [19].
Classification of mucosal pathology
Narrow band imaging with magnification was highly
accurate in predicting specialized intestinal metaplasia and
high grade dysplasia using the vascular and pit patterns
[ 2 0 ] .N a r r o wb a n di m a g i n gw a sa l s of o u n dt ob eu s e f u li n
differentiating adenomatous polyps from hyperplastic
colonic polyps and increasing the yield of polyps in
hyperplastic polyposis syndrome albeit giving no improve-
ment in adenoma detection rates [21,22]. I-Scan was found
to be as accurate as narrow band imaging in classifying
small colonic polyps [23], but more accurate in the setting
of bowel cancer screening [24].
Trimodal imaging
Commercially available endoscopes combining high
resolution chips (high resolution endoscopy), optical
magnification, narrow band imaging and autofluores-
cence imaging facilitate the use of all these image
enhancement techniques simultaneously and are often
referred to as ‘trimodal imaging’. The phenomenon of
autofluorescence occurs when a light of shorter wave-
length interacts with a tissue containing endogenous
fluorophores, which in turn emits light of longer
wavelength. A number of biological substances in the
gastrointestinal tract, such as collagen and elastin, can act
as endogenous fluorophores. Studies in Barrett’s eso-
phagus comparing trimodal imaging with standard
white light endoscopy in the diagnosis of dysplasia
have produced conflicting results. Earlier studies with
autofluorescence imaging have produced a high false
number of positive results but a good negative predictive
value. This has prompted the use of autofluorescence
imaging as a ‘red flag’ technique where the suspicious
areas are highlighted in ‘magenta’ over a background of
‘green’ and then closely examined with narrow band
imaging and magnification endoscopy [25]. A recent
randomized trial has shown that trimodal imaging
significantly improves the targeted detection of high
grade dysplasia and cancer compared with standard
white light endoscopy. Subsequent characterization of
lesions with narrow band imaging appeared to be of
limited value [26]. On the basis of the current available
evidence, trimodal imaging does not seem to improve
adenoma detection rates, compared with standard
endoscopy, and has only modest accuracy in characteriz-
ing polyps [27].
Confocal laser endomicroscopy
Anintegratedconfocalmicroscope(PentaxMedical),anda
probe-based confocal microscope (Mauna Kea technolo-
gies) are available commercially. Blue laser light is focused
on the desired tissue after injecting fluorescent materials,
which are excited by laser light and the confocal optical
unitdetectsthisatadefinedhorizontallevel.Magnification
up to 1000 times is obtained with this technology acqui-
ring images at the cellular level, mimicking histopathology
sections (Figure 3). Confocal laser endomicroscopy is
useful in differentiating gastric metaplasia from intestinal
type metaplasia in Barrett’s esophagus by identifying the
goblet cells (which replace normal epithelial cells in the
latter condition) [28]. The sensitivity in predicting intest-
inal metaplasia and dysplasia in Barrett’s esophagus
compared with targeted histology was 98% and 93%,
with a specificity of 94% and 98% respectively [29].
Confocal laser microscopy has also been used to detect
small bowel polyps and large bowel disorders with
commendable accuracy. However, this modality demands
technical expertise and is time consuming and its use is
thuslimitedtocentresofexcellence.Itisestimatedthat200
procedures are necessary before competence is achieved
[30].Thesystem,includingaconfocal laser endoscopeand
the processor, costs approximately £90,000 in the UK
($95,000 in the USA).
Optical coherence tomography
Optical coherence tomography (OCT) is an emerging
medical imaging technology that relies on the back-
scattering of light to obtain cross-sectional images of
tissue. OCT works on similar principles to ultrasound
but uses light waves to quantitatively measure back-
scattering, which is performed at each axial depth. OCT is
generally performed using catheters passed through the
working channel of endoscopes. In contrast to endo-
scopic ultrasound, this does not require a water interface
or tissue contact. Images are either linear or radial and
are acquired at a depth of 1-2 mm. Real time scanning is
possible to acquire high resolution images.
Initial studies have demonstrated that the individual
layers of the intestinal wall, including the mucosa,
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tissue (adventitia) are distinguishable using this techni-
que. Abnormal tissue layer patterns have been described
in various diseases [31]. A prospective biopsy correlated
study found that the sensitivity and specificity for
diagnosing intramucosal cancer and high grade dysplasia
in Barrett’s esophagus were 83% and 75%, respectively,
using an OCT image scoring system [32]. This technique
was also evaluated in small bowel, colon and biliary
tract. One study identified features of ulcerative colitis
on OCT, which correlated with histology despite the
epithelium appearing normal on white light endoscopy
[33]. Large randomised studies are necessary to sub-
stantiate the use of this emerging technology.
Other emerging technologies
Elastic scattering spectroscopy is a point measurement
using an appropriate optical geometry which senses
changes in the sub-cellular components and absorption
by hemoglobin [34]. This technique uses an optical probe
which is passed through the working channel of the
endoscope and white light is used from a xenon arc lamp.
The backscattered light from the upper layers of the tissue
is propagated to the spectrometer. A study in 81 patients
with matched optical and histological sites in Barrett’s
esophagus showed that the sensitivity for detection of high
grade dysplasia and cancer was 92% and specificity was
60%. Elastic scattering spectroscopy was also useful in
differentiating high risk sites from inflammatory areas with
commendable accuracy [35]. The role of this modality in
other areas of gastrointestinal tract is less well studied. The
currentdrawbackwithelasticscatteringspectroscopyisthat
it is limited to point analysis at optical biopsy sites
requiringmultipleapplicationsinordertoassessthewhole
field.
Raman spectroscopy provides molecular specific tissue
information through non-elastically scattered light of a
single wavelength light source such as a laser. The Raman
signal is often weak, necessitating intensive signal proces-
sing for its detection. This technique has been found to be
useful in identification and classification of neoplasia in
Barrett’s esophagus and differentiating hyperplastic and
adenomatous colonic polyps [36,37]. However, largely
this technique remains a research tool and more studies
are necessary to demonstrate its clinical value.
More recently, molecular targeted imaging has been
studied. The two most common probes developed thus
far are antibodies and peptides. Peptides are smaller in
size, easy to label with fluorescent dyes and have rapid
binding kinetics with minimal immunogenicity. A recent
Figure 3. Matched confocal laser endomicroscopy images of the epithelium and histology. Accredited to Prof. Ralf Kiesslich,
Universitätsmedizin, Mainz, Germany
The left  image is taken with a Pentax EG3870CIK endomicroscope following fluorescene injectionto highlight the vasculature. The cellular architecture can be
seen with large nuclei, loss of polarity and fluorescence leakage typical of in-situ carcinoma. The matching right image is an H&E stained histology section
demonstrating similar cellular architecture.
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binds to dysplasia in Barrett’s esophagus and can be
fluorescence labeled to target premalignant mucosa on
imaging [38].
Summary
Endoscopic imaging is rapidly evolving and, with the
advancement in electronics, high resolution endoscopes
with high definition monitors are able to identify subtle
mucosal abnormalities. Image enhancement techniques
with magnification have enabled us to visualize the
mucosal vascular and pit patterns and thus identify early
cancerous changes. ‘Optical biopsy’ techniques such as
confocal laser microscopy have not been widely used as
they are technically challenging. None of these techniques
are specific enough to avoid the need for histopathology
samplingandobtainingareal timediagnosis.Nonetheless,
they are helpful in targeting abnormal areas and thus help
in early diagnosis and endotherapy. Molecularly targeted
imaging using labeled peptides is exciting and promising.
The ideal optical system for assessing the gastrointestinal
tract is one which enables the user to accurately identify
and characterize pathology in vivo (see Table 1). In
addition, the technology should be easy to use without
extensive training, such that it does not present a barrier
to its use outside expert centers. In our opinion, there are
some technologies which have shown promise in meet-
ing these specifications. Raman spectroscopic mapping,
particularly with the introduction of a fiber probe may
allow immediate in vivo diagnosis of neoplasia. More-
over, the topical application of tumor-targeting Raman
nanoparticles enables the user to target specific areas of
abnormality as a ‘red flag’ technique, increasing the
sensitivity and accuracy of the technology. The other
technology we believe is likely to develop a role in
endoscopic imaging is OCT. There has been a marked
improvement in the resolution of OCT and the rate of
image requisition. Evaluation of tissue microstructure by
OCT on combination with fluorescence molecular
imaging is likely to yield information not only regarding
pathological processes but also vascular microstructure
and cellular architecture.
Abbreviations
FICE, Flexible spectral imaging colour enhancement;
OCT, Optical coherence tomography.
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